Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction

Hypertension

Volumn 27, Issue 3 I, 1996, Pages 346-353

  Keim, Malte ^a   Preik, Michael ^a   Hafner, Dieter J ^a   Strauer, Bodo E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

acetylcholine; arterial hypertension; bradykinin; endothelium; microcirculation; nitric oxide; vascular diseases

Indexed keywords

ACETYLCHOLINE; BRADYKININ; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HUMAN; HYPERTENSION; INTRAARTERIAL DRUG ADMINISTRATION; LASER FLOWMETER; MALE; MICROCIRCULATION; PATHOGENESIS; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0029883203     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.346     Document Type: Article

References (41)

1. Folkow B. Physiological aspects of primary hypertension. Physiol Rev. 1982;62:347-505.
2. Dzau VJ, Gibbons GH, Morishita R, Pratt RE. New perspectives in hypertension research: potentials of vascular biology. Hypertension. 1994;23:1132-1140.
3. Chobanian AV. Adaptive and maladaptive responses of the arterial wall to hypertension. Hypertension. 1989;15:666-674.
4. Mulvany MJ. Abnormalities of resistance vessel structure in essential hypertension: are these important? Clin Pharmacol Physiol. 1991;18:13-20.
5. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
6. Dominiczak AF, Bohr DF. Nitric oxide and its putative role in hypertension. Hypertension. 1995;25:1202-1211.
7. Alexander RW. Hypertension and the pathogenesis of atherosclerosis. Hypertension. 1995;25:155-161.
8. Ignarro LJ. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989;65:1-21.
9. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J. 1989;3:2007-2018.
10. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997-1000.
11. Stamler JS, Loh E, Roddy MA, Currie KE, Creager MA. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation. 1994;89:2035-2044.
12. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27.
13. Linder L, Kiowski W, Bühler FR, Lüscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation. 1990;81:1762-1767.
14. Hirooka Y, Imaizumi T, Masaki H, Ando S, Harada S, Momohara M, Takeshita A. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. Circulation. 1992;20:175-180.
15. Creager M, Roddy MA. Effect of captopril and enalapril on endothelial function in hypertensive patients. Hypertension. 1994;24:499-505.
16. Panza JA, Garcia CE, Kilcoyne CM, Quyyumi AA, Cannon RO III. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation. 1995;91:1732-1738.
17. Angus JA, Dyke AC, Jennings GL. Release of endothelium-derived relaxing factor from resistance arteries in hypertension. Kidney Int. 1992;37(suppl):S73-S78.
18. Cockroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N Engl J Med. 1994;330:1036-1040.
19. Chobanian AV. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Mud. 1988;148:1023-1038.
20. Graf K. Auswertung und Meßfehler okklusionsplethysmografischer Durchblutungsregistrierungen. Acta Physiol Scand. 1964;60:120-135.
21. Tenland T, Salerud EG, Nilsson G, Oberg PA. Spatial and temporal variations in human skin blood flow. Int J Microcirc Clin Exp. 1983;2:81-90.
22. Tooke JE, Östergren J, Fagrell B. Synchronous assessment of human skin microcirculation by laser Doppler flowmetry and dynamic capillaroscopy. Int J Microcirc Clin Exp. 1983;2:277-284.
23. Almond N. Laser Doppler flowmetry: theory and practice. In: Belcaro GV, Hoffmann U, Bollinger A, Nicolaides AN, eds. Laser Doppler. London/Los Angeles/Nicosia: Med-Orion Publishing; 1994:17-33.
24. Heavey DJ, Barrow SE, Hickling NE, Ritter JM. Aspirin causes short-lived inhibition of bradykinin-stimulated prostacyclin production in man. Nature. 1985;318:186-188.
25. Bruning TA, Hendriks MGC, Chang PC, Kuypers EAP, van Zwieten PA. In vivo characterization of vasodilating muscarinic-receptor subtypes in humans. Circ Res. 1994;74:912-919.
26. G-monomethyl-arginine attenuates the vasodilator action of bradykinin in the human forearm, Br J Clin Pharmacol. 1994;38:311-315.
27. Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation. 1993;87:1461-1477.
28. Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J Cardiovasc Pharmacol. 1991;17(suppl 3):S25-S33.
29. Carlsson I, Sollevi A, Wennmalm A. The role of myogenic relaxation, adenosine and prostaglandins in human forearm reactive hyperemia. J Physiol. 1987;389:147-161.
30. Takeshita A, Mark AL. Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hypertension. 1980;2:610-616.
31. Schulte KL, Braun J, Meyer-Sabellek W, Wegscheider K, Gotzen R, Distler A. Functional versus structural changes of forearm vascular resistance in hypertension. Hypertension. 1988;11:320-325.
32. Pedrinelli R, Catapano G, Dell'Omo G, Melillo E, Talarico L, DiMuro C, Giampietro O, Carmassi F, Giusti C, DiBello V. Forearm blood flow reserve and cardiac and renal indexes of pressure load in normotensive and hypertensive individuals. Hypertension. 1994;24:24-29.
33. Tagawa T, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994;90:2285-2290.
34. Robinson BF, Dobbs RJ, Bayley S. Response of forearm resistance vessels to verapamil and sodium nitroprusside in normotensive and hypertensive men: evidence for a functional abnormality of vascular smooth muscle in primary hypertension. Clin Sci. 1982;63:33-42.
35. Lancaster J. Simulation of the diffusion and the reaction of endogenously produced nitric oxide. Proc Natl Acad Sci U S A. 1994;91:8137-8142.
36. Keitoku M, Okayama H, Satoh Y, Maruyama Y, Takishima T. Does diffuse intimal thickening in human coronary artery act as diffusion barrier to endothelium-derived relaxing factor? Tohoku J Exp Med. 1990;154:413-414.
37. Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does Superoxide underlie the pathogenesis of hypertension? Proc Natl Acad Sci U S A. 1991;88:10045-10048.
38. Keim M, Feelisch M, Krebber T, Deußen A, Motz W, Strauer BE. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats: maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension. 1995;25:186-193.
39. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial Superoxide anion production. J Clin Invest. 1993;91:2546-2551.
40. Heagerty AM, Aalkjaer C, Bund SJ, Korsgaard N, Mulvany MJ. Small artery structure in hypertension: dual process of remodelling and growth. Hypertension. 1992;21:391-397.
41. Lüscher TF. The endothelium: target and promoter of hypertension? Hypertension. 1990;15:482-485.